Fulton Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $377K | Buy |
847
+274
| +48% | +$122K | 0.01% | 486 |
|
|
2025
Q1 | $278K | Sell |
573
-180
| -24% | -$87.3K | 0.01% | 549 |
|
|
2024
Q4 | $303K | Sell |
753
-45
| -6% | -$18.1K | 0.01% | 536 |
|
|
2024
Q3 | $371K | Sell |
798
-120
| -13% | -$55.8K | 0.01% | 499 |
|
|
2024
Q2 | $430K | Sell |
918
-3,146
| -77% | -$1.47M | 0.02% | 423 |
|
|
2024
Q1 | $1.7M | Sell |
4,064
-44
| -1% | -$18.4K | 0.07% | 204 |
|
|
2023
Q4 | $1.67M | Buy |
4,108
+59
| +1% | +$24K | 0.08% | 196 |
|
|
2023
Q3 | $1.41M | Sell |
4,049
-50
| -1% | -$17.4K | 0.07% | 207 |
|
|
2023
Q2 | $1.44M | Sell |
4,099
-631
| -13% | -$222K | 0.07% | 201 |
|
|
2023
Q1 | $1.49M | Buy |
4,730
+104
| +2% | +$32.8K | 0.08% | 193 |
|
|
2022
Q4 | $1.34M | Sell |
4,626
-3
| -0.1% | -$866 | 0.08% | 195 |
|
|
2022
Q3 | $1.34M | Sell |
4,629
-312
| -6% | -$90.4K | 0.08% | 188 |
|
|
2022
Q2 | $1.39M | Buy |
4,941
+643
| +15% | +$181K | 0.08% | 183 |
|
|
2022
Q1 | $1.12M | Buy |
+4,298
| New | +$1.12M | 0.05% | 225 |
|
|
2021
Q1 | – | Sell |
-4,640
| Closed | -$1.1M | – | 500 |
|
|
2020
Q4 | $1.1M | Buy |
4,640
+257
| +6% | +$60.8K | 0.06% | 202 |
|
|
2020
Q3 | $1.19M | Buy |
4,383
+1,223
| +39% | +$333K | 0.07% | 173 |
|
|
2020
Q2 | $917K | Buy |
+3,160
| New | +$917K | 0.06% | 206 |
|